Prostate Cancer Clinical Trial

Prostate Cancer Survey

Summary

There have been calls from patients, payers, healthcare providers, and policy makers for an evaluation of newer, high-cost radiation technologies compared to conventional forms of radiation therapy. National attention has focused on the use of intensity modulated radiation therapy (IMRT) into routine daily clinical practice for prostate cancer. The goal of the present study is to determine whether the type of radiation treatment received by the patients can result in a reduction in patient-relevant side effects following prostate irradiation. The analysis will be performed by obtaining patient answered surveys looking at side effects.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Participant is 18 years or older
Has been diagnosed with prostate cancer
Able to speak and read English

Exclusion Criteria:

Participant is not being seen for prostate cancer
Under the age of 18

Study is for people with:

Prostate Cancer

Estimated Enrollment:

224

Study ID:

NCT03128710

Recruitment Status:

Completed

Sponsor:

University of Maryland, Baltimore

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

UMMC
Baltimore Maryland, 21201, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

224

Study ID:

NCT03128710

Recruitment Status:

Completed

Sponsor:


University of Maryland, Baltimore

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider